Literature DB >> 33842932

A Bayesian Disease Progression Model for Clinical Trajectories.

Yingying Zhu1, Mert R Sabuncu1.   

Abstract

In this work, we consider the problem of predicting the course of a progressive disease, such as cancer or Alzheimer's. Progressive diseases often start with mild symptoms that might precede a diagnosis, and each patient follows their own trajectory. Patient trajectories exhibit wild variability, which can be associated with many factors such as geno-type, age, or sex. An additional layer of complexity is that, in real life, the amount and type of data available for each patient can differ significantly. For example, for one patient we might have no prior history, whereas for another patient we might have detailed clinical assessments obtained at multiple prior time-points. This paper presents a probabilistic model that can handle multiple modalities (including images and clinical assessments) and variable patient histories with irregular timings and missing entries, to predict clinical scores at future time-points. We use a sigmoidal function to model latent disease progression, which gives rise to clinical observations in our generative model. We implemented an approximate Bayesian inference strategy on the proposed model to estimate the parameters on data from a large population of subjects. Furthermore, the Bayesian framework enables the model to automatically fine-tune its predictions based on historical observations that might be available on the test subject. We applied our method to a longitudinal Alzheimer's disease dataset with more than 3,000 subjects [1] with comparisons against several benchmarks.

Entities:  

Year:  2018        PMID: 33842932      PMCID: PMC8034262          DOI: 10.1007/978-3-030-00689-1_6

Source DB:  PubMed          Journal:  Graphs Biomed Image Anal Integr Med Imaging Nonimaging Modalities (2018)


  17 in total

1.  2010 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

2.  Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study.

Authors:  Sid E O'Bryant; Stephen C Waring; C Munro Cullum; James Hall; Laura Lacritz; Paul J Massman; Philip J Lupo; Joan S Reisch; Rachelle Doody
Journal:  Arch Neurol       Date:  2008-08

3.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

4.  The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts.

Authors:  Stefan J Cano; Holly B Posner; Margaret L Moline; Stephen W Hurt; Jina Swartz; Tim Hsu; Jeremy C Hobart
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-29       Impact factor: 10.154

5.  Modelling mini mental state examination changes in Alzheimer's disease.

Authors:  M S Mendiondo; J W Ashford; R J Kryscio; F A Schmitt
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

6.  Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

Authors:  Sean M Nestor; Raul Rupsingh; Michael Borrie; Matthew Smith; Vittorio Accomazzi; Jennie L Wells; Jennifer Fogarty; Robert Bartha
Journal:  Brain       Date:  2008-07-11       Impact factor: 13.501

Review 7.  Cognitive reserve in ageing and Alzheimer's disease.

Authors:  Yaakov Stern
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

8.  Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.

Authors:  R C Petersen; P S Aisen; L A Beckett; M C Donohue; A C Gamst; D J Harvey; C R Jack; W J Jagust; L M Shaw; A W Toga; J Q Trojanowski; M W Weiner
Journal:  Neurology       Date:  2009-12-30       Impact factor: 9.910

9.  Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education.

Authors:  L Fratiglioni; M Grut; Y Forsell; M Viitanen; M Grafström; K Holmén; K Ericsson; L Bäckman; A Ahlbom; B Winblad
Journal:  Neurology       Date:  1991-12       Impact factor: 9.910

10.  Polygenic risk of Alzheimer disease is associated with early- and late-life processes.

Authors:  Elizabeth C Mormino; Reisa A Sperling; Avram J Holmes; Randy L Buckner; Philip L De Jager; Jordan W Smoller; Mert R Sabuncu
Journal:  Neurology       Date:  2016-07-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.